U.S. Minoxidil Market Size and Share | Statistics - 2027

U.S. Minoxidil Market Size By Product (5%, 2%), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Industry Analysis Report, Country Outlook, Application Development Potential, Price Trend, Competitive Market Share & Forecast, 2021 – 2027

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Market definitions

1.2&nbsp;&nbsp;&nbsp; Base estimates &amp; calculations

1.3&nbsp;&nbsp;&nbsp; Forecast calculation

1.4&nbsp;&nbsp;&nbsp; Data Sources

1.4.1&nbsp;&nbsp;&nbsp; Primary

1.4.2&nbsp;&nbsp;&nbsp; Secondary

1.4.2.1&nbsp;&nbsp;&nbsp; Paid Sources

1.4.2.2&nbsp;&nbsp;&nbsp; Public Sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; U.S. minoxidil industry 3600&nbsp;synopsis, 2016 - 2027

2.1.1&nbsp;&nbsp;&nbsp; Business Trends

2.1.2&nbsp;&nbsp;&nbsp; Product trends

2.1.3&nbsp;&nbsp;&nbsp; Distribution channel trends

Chapter 3&nbsp;&nbsp;&nbsp;US Minoxidil Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry segmentation

3.2&nbsp;&nbsp;&nbsp; Impact of COVID-19 on global economy

3.3&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.3.1&nbsp;&nbsp;&nbsp; Raw materials

3.3.2&nbsp;&nbsp;&nbsp; Manufacturers

3.3.3&nbsp;&nbsp;&nbsp; Distributors

3.3.4&nbsp;&nbsp;&nbsp; Distribution channel analysis

3.3.5&nbsp;&nbsp;&nbsp; Profit margin trend

3.3.6&nbsp;&nbsp;&nbsp; Vendor matrix

3.3.7&nbsp;&nbsp;&nbsp; COVID-19 impact on value chain

3.4&nbsp;&nbsp;&nbsp; Regulatory landscape

3.4.1&nbsp;&nbsp;&nbsp; U.S.

3.4.1.1&nbsp;&nbsp;&nbsp; Department of Health and Human Services (NDA 021812/S-009)

3.5&nbsp;&nbsp;&nbsp; Raw material analysis

3.5.1&nbsp;&nbsp;&nbsp; Impact of COVID-19 on raw material supply

3.6&nbsp;&nbsp;&nbsp; Technology Landscape

3.6.1&nbsp;&nbsp;&nbsp; Potential application scenario

3.6.1.1&nbsp;&nbsp;&nbsp; Minoxidil for beard growth

3.6.1.2&nbsp;&nbsp;&nbsp; Alternative minoxidil formulations

3.6.2&nbsp;&nbsp;&nbsp; Formulation Process

3.6.3&nbsp;&nbsp;&nbsp; Solid lipid nanoparticles

3.6.4&nbsp;&nbsp;&nbsp; Propylene glycol minoxidil topical formulation for hair loss

3.7&nbsp;&nbsp;&nbsp; Global alopecia industry scenario

3.7.1&nbsp;&nbsp;&nbsp; Minoxidil vs other hair loss treatments

3.7.1.1&nbsp;&nbsp;&nbsp; Dermatology Uses of Minoxidil

3.7.1.1.1&nbsp;&nbsp;&nbsp; Androgenetic Alopecia (AGA)

3.7.1.1.2&nbsp;&nbsp;&nbsp; Hair Transplant

3.7.1.1.3&nbsp;&nbsp;&nbsp; Alopecia Areata

3.7.1.2&nbsp;&nbsp;&nbsp; Minoxidil Side Effects

3.7.1.3&nbsp;&nbsp;&nbsp; Other Hair Loss Treatments

3.7.1.3.1&nbsp;&nbsp;&nbsp; Androgen-dependent medications

3.7.1.4&nbsp;&nbsp;&nbsp; New users % in U.S. for 2017, 2018, 2019, and 2020

3.7.1.4.1&nbsp;&nbsp;&nbsp; Demographic trends

3.7.1.4.2&nbsp;&nbsp;&nbsp; Consumer buying behaviour

3.7.1.4.2.1&nbsp;&nbsp;&nbsp; Unmet needs

3.7.1.4.2.2&nbsp;&nbsp;&nbsp; Social &amp; Cultural impact forces

3.7.1.4.2.3&nbsp;&nbsp;&nbsp; Information search

3.7.1.4.2.4&nbsp;&nbsp;&nbsp; Evaluation of alternative

3.7.1.4.2.5&nbsp;&nbsp;&nbsp; Purchase decision

3.7.1.4.2.6&nbsp;&nbsp;&nbsp; Post purchase evaluation

3.7.2&nbsp;&nbsp;&nbsp; Impact of COVID-19 on consumer buying behavior

3.8&nbsp;&nbsp;&nbsp; Industry best practices and key buying criteria

3.9&nbsp;&nbsp;&nbsp; Industry impact forces

3.9.1&nbsp;&nbsp;&nbsp; Growth drivers

3.9.1.1&nbsp;&nbsp;&nbsp; Growing consumer spending on hair care products accompanied by expanding distribution channel

3.9.1.2&nbsp;&nbsp;&nbsp; Developing personal care market along with the increasing prevalence of alopecia areata

3.9.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.9.2.1&nbsp;&nbsp;&nbsp; Stringent regulations along with possible side effects of minoxidil

3.10&nbsp;&nbsp;&nbsp; Pricing analysis, 2016 -2027

3.10.1&nbsp;&nbsp;&nbsp; Impact of COVID-19 on regional pricing

3.11&nbsp;&nbsp;&nbsp; Cost structure analysis, 2020

3.12&nbsp;&nbsp;&nbsp; Growth potential analysis, 2020

3.12.1&nbsp;&nbsp;&nbsp; Emerging business models

3.12.1.1&nbsp;&nbsp;&nbsp; Merger &amp; Acquisition

3.12.1.2&nbsp;&nbsp;&nbsp; Capacity expansion

3.12.1.1&nbsp;&nbsp;&nbsp; Expansion of distribution network

3.13&nbsp;&nbsp;&nbsp; Porter&rsquo;s analysis

3.13.1&nbsp;&nbsp;&nbsp; Threat of new entrants

3.13.2&nbsp;&nbsp;&nbsp; Supplier power

3.13.3&nbsp;&nbsp;&nbsp; Buyer power

3.13.4&nbsp;&nbsp;&nbsp; Threat of substitutes

3.14&nbsp;&nbsp;&nbsp; Competitive landscape, 2020

3.14.1&nbsp;&nbsp;&nbsp; Company market share analysis, 2020

3.14.2&nbsp;&nbsp;&nbsp; Top players overview

3.14.3&nbsp;&nbsp;&nbsp; Strategy Dashboard

3.15&nbsp;&nbsp;&nbsp; PESTLE analysis

3.16&nbsp;&nbsp;&nbsp; COVID-19 impact on U.S. cosmetics industry

Chapter 4&nbsp;&nbsp;&nbsp;US Minoxidil Market, By Product

4.1&nbsp;&nbsp;&nbsp; Key product trends

4.2&nbsp;&nbsp;&nbsp; 5% minoxidil

4.2.1&nbsp;&nbsp;&nbsp; U.S. minoxidil market estimates and forecast from 5% minoxidil, 2016 - 2027, (Thousand Units) (USD Million)

4.3&nbsp;&nbsp;&nbsp; 2% minoxidil

4.3.1&nbsp;&nbsp;&nbsp; U.S. minoxidil market estimates and forecast from 2% minoxidil, 2016 - 2027, (Thousand Units) (USD Million)

Chapter 5&nbsp;&nbsp;&nbsp;US Minoxidil Market, By Distribution Channel

5.1&nbsp;&nbsp;&nbsp; Key distribution channel trends

5.2&nbsp;&nbsp;&nbsp; Hospital pharmacies

5.2.1&nbsp;&nbsp;&nbsp; U.S. minoxidil market estimates and forecast from hospital pharmacies, 2016 - 2027, (Thousand Units) (USD Million)

5.3&nbsp;&nbsp;&nbsp; Retail pharmacies

5.3.1&nbsp;&nbsp;&nbsp; U.S. minoxidil market estimates and forecast from retail pharmacies, 2016 - 2027, (Thousand Units) (USD Million)

5.4&nbsp;&nbsp;&nbsp; Online pharmacies

5.4.1&nbsp;&nbsp;&nbsp; U.S. minoxidil market estimates and forecast from online pharmacies, 2016 - 2027, (Thousand Units) (USD Million)

Chapter 6&nbsp;&nbsp;&nbsp;Company Profiles

6.1&nbsp;&nbsp;&nbsp; Kumar Organic Products Limited

6.1.1&nbsp;&nbsp;&nbsp; Business Overview

6.1.2&nbsp;&nbsp;&nbsp; Financial Data

6.1.3&nbsp;&nbsp;&nbsp; Product Landscape

6.1.4&nbsp;&nbsp;&nbsp; Strategic Outlook

6.1.5&nbsp;&nbsp;&nbsp; SWOT Analysis

6.2&nbsp;&nbsp;&nbsp; Par Pharmaceuticals

6.2.1&nbsp;&nbsp;&nbsp; Business Overview

6.2.2&nbsp;&nbsp;&nbsp; Financial Data

6.2.3&nbsp;&nbsp;&nbsp; Product Landscape

6.2.4&nbsp;&nbsp;&nbsp; SWOT Analysis

6.3&nbsp;&nbsp;&nbsp; Metapharmaceutical Ind. S.L.

6.3.1&nbsp;&nbsp;&nbsp; Business Overview

6.3.2&nbsp;&nbsp;&nbsp; Financial Data

6.3.3&nbsp;&nbsp;&nbsp; Product Landscape

6.3.4&nbsp;&nbsp;&nbsp; SWOT Analysis

6.4&nbsp;&nbsp;&nbsp; Johnson &amp; Johnson Consumer Inc

6.4.1&nbsp;&nbsp;&nbsp; Business Overview

6.4.2&nbsp;&nbsp;&nbsp; Financial Data

6.4.3&nbsp;&nbsp;&nbsp; Product Landscape

6.4.4&nbsp;&nbsp;&nbsp; SWOT Analysis

6.5&nbsp;&nbsp;&nbsp; FLAMMA GROUP

6.5.1&nbsp;&nbsp;&nbsp; Business Overview

6.5.2&nbsp;&nbsp;&nbsp; Financial Data

6.5.3&nbsp;&nbsp;&nbsp; Product Landscape

6.5.4&nbsp;&nbsp;&nbsp; SWOT Analysis

6.6&nbsp;&nbsp;&nbsp; LGM Pharma

6.6.1&nbsp;&nbsp;&nbsp; Business Overview

6.6.2&nbsp;&nbsp;&nbsp; Financial Data

6.6.3&nbsp;&nbsp;&nbsp; Product Landscape

6.6.4&nbsp;&nbsp;&nbsp; Strategic Outlook

6.6.5&nbsp;&nbsp;&nbsp; Swot Analysis

6.7&nbsp;&nbsp;&nbsp; Perrigo Company PLC

6.7.1&nbsp;&nbsp;&nbsp; Business Overview

6.7.2&nbsp;&nbsp;&nbsp; Financial Data

6.7.3&nbsp;&nbsp;&nbsp; Product Landscape

6.7.4&nbsp;&nbsp;&nbsp; SWOT Analysis

6.8&nbsp;&nbsp;&nbsp; Renata Limited

6.8.1&nbsp;&nbsp;&nbsp; Business Overview

6.8.2&nbsp;&nbsp;&nbsp; Financial Data

6.8.3&nbsp;&nbsp;&nbsp; Product Landscape

6.8.4&nbsp;&nbsp;&nbsp; Strategic outlook

6.8.5&nbsp;&nbsp;&nbsp; SWOT Analysis

6.9&nbsp;&nbsp;&nbsp; Costco Wholesale Corporation

6.9.1&nbsp;&nbsp;&nbsp; Business Overview

6.9.2&nbsp;&nbsp;&nbsp; Financial Data

6.9.3&nbsp;&nbsp;&nbsp; Product Landscape

6.9.4&nbsp;&nbsp;&nbsp; SWOT Analysis

6.10&nbsp;&nbsp;&nbsp; Walmart

6.10.1&nbsp;&nbsp;&nbsp; Business Overview

6.10.2&nbsp;&nbsp;&nbsp; Financial Data

6.10.3&nbsp;&nbsp;&nbsp; Product Landscape

6.10.4&nbsp;&nbsp;&nbsp; SWOT Analysis

6.11&nbsp;&nbsp;&nbsp; Nanz Med Science Pharma Private Limited

6.11.1&nbsp;&nbsp;&nbsp; Business Overview

6.11.2&nbsp;&nbsp;&nbsp; Financial Data

6.11.3&nbsp;&nbsp;&nbsp; Product Landscape

6.11.4&nbsp;&nbsp;&nbsp; SWOT Analysis 
&nbsp;

US Minoxidil Market

Get a free sample of this report

Industries

Information

Link

Global Headquarters